Elucidation of the association between sarcopenia and accumulated risks of cerebrovascular disease and its predictive factors in patients with type 2 diabetes mellitus

JRCT ID: jRCT1030230057

Registered date:29/04/2023

Basic Information

• Recruitment status: Not Recruiting
• Health condition(s) or Problem(s) studied: Type 2 diabetes
• Date of first enrollment: 15/10/2021
• Target sample size: 450
• Study type: Observational

Outcome(s)

• Primary Outcome: Multiple CVD risks (number of complications of diabetes, dyslipidemia, and hypertension)

Secondary Outcome

Phase angle
Sarcopenia evaluation indices
Obesity evaluation indices
Glucose metabolism indices
Lipid metabolism indices
Blood pressure indices
All-cause mortality and CVD events

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: Not applicable
• Gender: Both

Include criteria

Patients who satisfy all of the following criteria.
(1) Type 2 diabetes
(2) Lower age limit: 20 years old
(3) Gender: male and female
(4) Outpatients visiting hospitals of the National Hospital Organization
(5) Patients who have provided written informed consent

Exclude criteria

Patients who fall under any of the following criteria.
(1) Patients with AST or ALT above 100 U/L
(2) Patients with Cre above 3.0 mg/dL
(3) Female patients who are suspected of being pregnant or pregnant
(4) Patients with previous history of angioplasty and bypass surgery, history of hospitalization for heart failure treatment within the past one year
(5) Patients with cancer with a history or treatment within five years
(6) Patients taking corticosteroids
(7) Patients with defects in their limbs
(8) Patients wearing pacemakers
(9) Patients judged by the investigator/projectleader to be ineligible for other reasons

Related Information

• Primary Sponsor: Kusakabe Toru
• Source(s) of Monetary Support: National Hospital Organization